帯状疱疹後神経痛患者における右背外側前頭前野の血行動態の障害は、プラシーボ効果の障害および臨床症状に関与する by 日比 大亮
 1 
 
 
 
 
Impaired hemodynamic activity in the right dorsolateral prefrontal 
cortex is associated with impairment of placebo analgesia and 
clinical symptoms in postherpetic neuralgia 
 
 
 
 
 
 
 
 
 
 
Daisuke Hibi 
 
Department of Anesthesiology, Graduate School of Medicine and Pharmaceutical Sciences, 
University of Toyama, Japan 
 
  
 2 
Abstract 
 
The dorsolateral prefrontal cortex (dlPFC) is functionally linked to the descending pain 
modulation system and has been implicated in top down pain inhibition, including placebo 
analgesia. Therefore, functions of the dlPFC may be impaired in patients with chronic pain. 
Postherpetic neuralgia (PHN) is one of several syndromes with chronic neuropathic pain. In the 
present study, I investigated possible dysfunction of the dlPFC in chronic pain using patients 
with PHN. In a conditioning phase, heathy controls (n=15) and patients with PHN (n=7) were 
exposed to low (LF) and high (HF) frequency tones associated with noxious stimuli: weak (WS) 
and strong (SS) electrical stimulation, respectively. After the conditioning, cerebral 
hemodynamic activity was recorded from the bilateral dlPFC while the subjects were subjected 
to the cue tone-noxious electrical stimulation paradigm, in which incorrectly cued noxious 
stimuli were sometimes delivered to induce placebo and nocebo effects. The results indicated 
that hemodynamic responses to the LF tone in the right dlPFC was significantly lower in patients 
with PHN compared to the healthy controls. Furthermore, the same hemodynamic responses in 
the right dlPFC were correlated with placebo effects. In addition, clinical symptoms of PHN 
were negatively correlated to cerebral hemodynamic responses in the right dlPFC and 
magnitudes of the placebo effects. The results suggest that the right dlPFC, which is closely 
associated with the descending pain modulation system, is disturbed in PHN. 
 
Key words: postherpetic neuralgia; chronic pain; dorsolateral prefrontal cortex; hemodynamic 
responses; placebo analgesia 
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1. Introduction 
 
 One-third to one-half of the population suffers from chronic pain (Fayaz et al., 2016). 
Chronic pain seriously impairs quality of life (QOL), activities of daily living, and patients’ 
social and family environments (Dueñas et al., 2016). Postherpetic neuralgia (PHN) is a typical 
chronic neuropathic pain syndrome consisting of symptoms such as spontaneous pain, tactile 
allodynia, and hyperpathia, which may develop after the healing of herpes zoster eruptions. 
About 30% of patients with PHN are considered refractory to current treatments (Watson and 
Oaklander, 2002), and neural mechanisms of neuropathic pain in PHN remain under debate 
(Miyazaki et al., 2005; Devor, 2018). Several studies suggest that disturbance of the descending 
pain modulation system is involved in the development of chronic pain (see review by Ossipov 
et al., 2014). Moreover, a recent clinical study reported that conditioned pain modulation was 
disturbed in patients with PHN, and impairment in conditioned pain modulation was correlated 
with clinical pain symptoms (Pickering et al., 2014). These findings suggest that the pain-
inhibition system is disturbed in PHN (Pickering et al., 2014). 
 The dorsolateral prefrontal cortex (dlPFC) has been implicated in pain inhibition through 
effects on the descending pain modulation system (Lorenz et al., 2003; Craggs et al., 2007; 
Tracey and Mantyh, 2007). Activity of the dlPFC has been shown to increase in response to cues 
predicting a stressful unconditioned stimulus and inhibit activity of the amygdala in response to 
the unconditioned stimulus (Goodmann et al., 2018). Placebo analgesia is experimentally 
induced by presenting specific cues associated with lower pain (i.e., expectation of lower pain) 
(Wager and Atlas, 2015). Activity in the dlPFC in response to a cue predicting lower noxious 
pain was correlated with placebo effects, as well as with activity in the descending pain 
modulating system (Wager et al., 2004). Furthermore, gray matter density in the dlPFC was 
correlated to placebo analgesia (Schweinhardt et al., 2009). These findings suggest that the 
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dlPFC plays an important role in pain inhibition.  
 In patients with chronic pain, it has been proposed that differential associative learning of 
conditioned stimuli (CSs) is impaired when CSs are differentially associated with strong/weak 
and noxious/non-noxious events (Schneider et al., 2004; Jenewein et al., 2013; Meulders et al., 
2014, 2015; Harvie et al., 2017). These studies suggest that deficits in identifying the safe cue 
(i.e., CSs associated with weak noxious or non-noxious events) lead to elevated anxiety and fear. 
Subsequently, deficits in inhibiting fear responses in the presence of safe CSs may lead to 
chronic pain (Meulders et al., 2014, 2015), since pain-related fear is an important factor for 
development of chronic pain (Zale et al., 2013). The substantial role of the dlPFC in placebo 
analgesia suggests involvement of the dlPFC in associative conditioning to induce placebo 
effects. 
 Accumulating evidence suggests that the dlPFC is morphologically and functionally 
altered in patients with chronic pain (Seminowicz and Moayediz, 2017; Ong et al., 2019). In the 
present study, I hypothesized that functional alteration in the dlPFC might be associated with 
impairments in differential associative conditioning in patients with PHN. To investigate this 
idea, I analyzed hemodynamic activity in the dlPFC using near-infrared spectroscopy (NIRS) 
during differential associative conditioning, in which two different CSs were associated with 
weak and strong electrical stimulation. Herein, I report that the hemodynamic responses to the 
CSs associated with weak stimulation were decreased in patients with PHN, which was further 
associated with clinical pain symptoms and deficits in placebo effects. 
 
 
2. Materials and methods 
 
2.1. Participants 
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Seven patients with postherpetic neuralgia (PHN) diagnosed according to the diagnostic 
criteria proposed by the international association for the study of pain (IASP) were recruited 
from Department of Anesthesiology at the Toyama University Hospital. There were 4 male 
patients, 3 female patients, and the mean age of the patients was 67.29±2.62 years 
(mean±standard error [SE]). The inclusion criteria for the patients with PHN were: (1) patients 
who received appropriate antiviral treatment; (2) persistent pain lasting longer than three months 
after the onset of herpes zoster infection; (3) over fifty years of age. The exclusion criteria for the 
patients with PHN were: (1) patients had psychiatric disorders; (2) patients had neurological 
disorder(s) apart from PHN. Fifteen age- and sex-matched healthy controls (HC) who had no 
neurological or psychiatric disorders (males, 7; females, 8; mean age, 66.33±1.64 years) 
participated in the present study. All participants were right-handed and had no cognitive 
impairment assessed by the Japanese version of Mini-Mental State Examination (J-MMSE) 
(Sugishita et al., 2016). This study followed the guidelines set forth by the Helsinki Declaration 
and was approved by the Ethical Committee for Human Clinical studies at University of 
Toyama. Written informed consent was obtained from all subjects who participated in this study. 
 
2.2. Experimental procedures 
First, current intensity of electrical cutaneous stimulation (painful stimuli) was determined. 
A conditioning session was then conducted, where subjects learned the association between two 
different cue tones and two different intensities of electrical stimulation in a cue tone-shock 
associative task. Finally, a recording session was conducted to measure the cerebral 
hemodynamic activity in the PFC during the cue tone-shock association task. The same pairs of 
cue tones and electrical stimulations as previously used in the conditioning session were 
presented in 75% of trials. Different combinations of the cue tones and electrical stimulations 
were presented (mismatch condition) in the remaining 25% of trials.  
 6 
To determine current intensity of electrical stimulation, electrodes were placed on the 
subject’s back of the left hand, which was not affected by PHN. Electrical stimulation was 
delivered by 5 Hz sine-wave electrical stimulator (Neurometer, Neurotron Inc., Baltimore, 
Maryland, USA). While current intensity was slowly increased, the subjects were instructed to 
say “yes” when they felt maximum tolerable pain on a scale of 0 to 100 [from 0 (no pain) to 100 
(maximum tolerable pain)]. Two intensities of electrical stimulation were determined based on 
the individual’s maximum tolerable pain threshold: 50% of the current intensity of the maximum 
tolerable pain (weak electrical stimulation: WS) and 90 % of the current intensity of the 
maximum tolerable pain (strong electrical stimulation: SS). 
During the conditioning session, the subjects completed 20 trials to associate cue tones and 
the corresponding electrical stimulation. Each trial consisted of the presentation of a cue tone (5 
s), electrical stimulation (5 s), and rest (10 s). Low-frequency (LF: 500 Hz, 60 db) and high-
frequency (HF: 2000Hz, 87db) cue tones were associated with WS and SS, respectively; 10 trials 
of LF cues-WS and another 10 trials of HF cue tones-SS were randomly presented. At the end of 
each electrical stimulation, subjects were asked to rate subjective pain intensity using a visual 
analog scale (VAS) [from 0 (no pain) to 100 (maximum tolerable pain)]. 
During the recording session, cerebral hemodynamic activity was measured by NIRS. Each 
trial consisted of the presentation of a cue tone (5 s), a delay period before electrical stimulation 
(5 s), electrical stimulation (5 s), and rest (20 to 30 s). A total of 32 trials were performed. These 
32 trials were divided into four conditions, including mismatch conditions: LF-WS condition (13 
trials), in which the LF cue tone was associated with WS (correctly cued stimulation); HF-SS 
condition (11 trials), in which the HF cue tone was associated with SS (correctly cued 
stimulation); LF-SS condition (4 trials), in which the LF cue tone was associated with SS 
(incorrectly cued stimulation); HF-WS condition (4 trials), in which the HF cue tone was 
associated with WS (incorrectly cued stimulation). Thus, the ratio of mismatched cued stimuli 
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vs. matched cued stimuli was 1:3. The matched and mismatched cued stimuli were pseudo-
randomly presented. At the end of each electrical stimulation, subjects were asked to rate 
subjective pain intensity using the visual analog scale. 
 
2.3. Psychological data analysis 
VAS pain in response to each electrical stimulation (WS or SS) were analyzed using 
repeated measures two-way analysis of variance (ANOVA) with the cue tone and subject group 
as factors. To assess placebo effects, VAS pain differences between the LF-SS and HF-SS 
conditions were computed for each participant, i.e., [(LF-SS) – (HF-SS)]. The placebo data in 
patients with PHN and HC were compared using the Mann-Whitney U test. To assess nocebo 
effects, VAS pain differences between the LF-LS and HF-WS conditions were computed in each 
subject, i.e., [(HF-WS) – (LF-WS)]. The nocebo data in patients with PHN and HC were 
compared using the Student's t-test. 
 
2.4. NIRS data recording 
Cerebral hemodynamic activity was measured by two NIRS systems (OMM 3000, 
Shimadzu Inc., Kyoto). The NIRS head cap was placed on the heads of the subjects. The 28 
source probes and 32 detector probes were placed on the head cap. The 27 detector probes were 
placed 3 cm away from the source probes, while 5 detector probes were placed 1.5 cm away 
from the source probes (Fig. 1A). The most anterior and lowest NIRS probes were placed at the 
FP10 FP2 line of the international 10-20 method for EEG recording (Jurcak et al., 2007). The 
midpoint of the source and detector probes, from which the NIRS signals were derived, were 
defined as NIRS channels (Fig. 1B). Hemodynamic activity was measured by light with different 
wave lengths (708, 805, and 830 nm). The changes in hemoglobin concentration (Oxy-Hb, 
Deoxy-Hb, and Total Hb) were estimated based on the modified Lambert-Beer law (Seiyama et 
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al., 1988; Wary et al., 1988). After the experiments, the three-dimensional coordinates of the 
probes and NIRS channels in each subject were measured by a digitizer (FASTRAK, Polhemus 
Inc., USA). 
 
2.5. NIRS data analysis 
As NIRS signals include both cerebral and extra-cerebral hemodynamic components, I 
applied a multi-distance probe arrangement method to remove the extra-cerebral components 
from NIRS signals (Sato et al., 2016; Ishikuro et al., 2014; Saager et al., 2011; Nakamichi et al., 
2018). When the distance between the source and detector probes was at 3 cm, NIRS signals 
include both cerebral and extracerebral (scalp, skull, and cerebrospinal fluid) hemodynamic 
signals (whole component signals). Additionally, NIRS signals mainly include the extracerebral 
hemodynamic component when the distance between source and detector probes was 1.5 cm 
(Fukui et al., 2003; Niederer et al., 2008). Thus, cerebral hemodynamic responses (Oxy-Hb, 
Deoxy-Hb, and Total-Hb) were estimated by simple-subtraction methods (Schytz et al., 2009). 
Cerebral components of the signals were estimated by subtracting the extra-cerebral signals 
located nearest to corresponding whole component signals from the whole component signals, 
i.e., [(whole component signals) – (extra-cerebral signals)]. To remove physiological noises due 
to respiration, cardiac activity, and baseline drifts, the band pass filter was set at 0.01 Hz to 0.1 
Hz (Tong et al., 2011; Yasumura et al., 2014). NIRS signals in each trial were summed and 
averaged to analyze hemodynamic responses to the cue tones. Averaged responses were 
corrected for the mean baseline activity from -8 to - 5 s before the onset of the cue tones. 
Since Oxy-Hb best reflects brain activity (Hoshi et al., 2001), Oxy-Hb data were analyzed 
to compare hemodynamic responses during presentation of auditory cues between patients with 
PHN and HC. Effect sizes of hemodynamic responses to the cue tones were calculated according 
to the following formula: effect size = [(mean Oxy-Hb levels for 10 s from cue tone onset) – 
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(mean Oxy-Hb levels during the baseline period from -8 to -5 s before cue tone onset)] / 
[standard deviation of Oxy-Hb levels during the baseline period from -8 to -5 s before cue tone 
onset].  
To identify the anatomical location in each channel, three-dimensional coordinates of the 
NIRS channels in each subject were normalized to the MNI coordinates using virtual registration 
(Tsuzuki et al., 2007). Subsequently, locations of NIRS channels in each Brodmann area (BA) 
were estimated using the MRIcro software (http://www.MRIcro.com) in each subject (Fig. 1C). 
In the present study, I defined the regions of interest (ROIs) as the right and left dorsolateral 
prefrontal cortex (dlPFC: BA9, 46). The effect sizes of the Oxy-Hb data derived from the 
channels within each ROI were averaged in each ROI in each subject. 
Hemodynamic responses (effect sizes) in the dlPFC to LF cue tones were analyzed using 
repeated measures two-way analysis of variance (ANOVA) with ROI and subject group as 
factors. When HF cue tones were presented, the data did not show normal distribution (see 
below), and hemodynamic responses to HF cue tone were compared between HC and patients 
with PHN using the Kruskal-Wallis test. 
 
2.6. Correlation analysis 
Correlations among NIRS responses in the dlPFC, clinical symptoms (numerical rating 
scale, NRS), and psychological data (placebo and nocebo effects) were analyzed using simple 
regression analysis. In these analyses, NRS=0 was used for the clinical symptoms in the HC 
subjects. 
 
2.7. Statistical Analysis 
All of the data are presented as mean ± standard error. All data were tested for normal 
distribution using the Kolmogorov-Smirnov test. Homogeneity of variance for repeated measures 
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two-way ANOVA was evaluated using Mauchly’s test of sphericity. The baseline characteristics 
of the subjects (age, current intensity of electrical stimulation, and MMSE) were compared 
between patients with PHN and HC using the independent Student’s t-test or the Mann-Whitney 
U test. The chi-square test was used to compare gender between patients with PHN and HC. All 
statistical analysis was performed using SPSS (IBM Inc., New York, USA). The statistical 
significance level was set at P < 0.05.  
 
 
3. Results 
 
3.1. Baseline characteristics  
Table 1 shows clinical characteristics of the patients with PHN, who had histories of 
chronic pain ranging from 3 to 45 months. Table 2 shows the baseline characteristics in patients 
with PHN and HC. There were no significant differences in age, sex, current intensity for 
maximum tolerable pain, or MMSE scores of the base line characteristics between patients with 
PHN and HC (Student’s t-test and χ2 test, P > 0.05).  
 
3.2. Changes in subjective pain perception 
Figure 2 shows the comparisons of subjective pain scores (VAS pain) in each condition 
between patients with PHN and HC. When SSs were delivered (Figure 2A), repeated measures 
two-way ANOVA (condition x subject group) revealed a significant main effect of condition [F 
(1, 20) = 48.53, P < 0.01] and a significant interaction between condition and subject group [F (1, 
20) = 18.41, P < 0.01]. However, there was no significant main effect of subject group [F (1,20) 
= 1.46, P > 0.05] (Figure 2A). Post-hoc comparisons indicated that VAS pain was significantly 
lower in the LF-SS condition compared with the HF-SS condition in HC (P < 0.01, Bonferroni 
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test). In the LF-SS (mismatched) condition, VAS pain tended to be lower in HC than in patients 
with PHN (P = 0.054, Bonferroni test). The VAS pain differences between the LF-SS and HF-SS 
conditions (i.e., placebo effects) were significantly greater in HC than in patients with PHN, 
which shows a greater pain reduction in HC (Student’s t-test, P < 0.01) (Figure 2B). When WSs 
were delivered (Figure 2C), repeated measures two-way ANOVA (condition x subject group) 
revealed a significant main effect of condition [F (1,20) = 22.23, P < 0.01] and a significant 
interaction between condition and subject group [F (1, 20) = 8.28, P < 0.01]. However, there was 
no significant main effect of subject group [F (1,20) = 2.54, P > 0.05]. Post-hoc comparisons 
indicated that VAS pain was significantly higher in the HF-WS condition than the LF-WS 
condition in HC (P < 0.01, Bonferroni test). In the HF-WS (mismatched) condition, VAS pain 
was significantly higher in HC than in patients with PHN (P < 0.05, Bonferroni test). The VAS 
pain differences between HF-WS and LF-WS conditions (i.e., nocebo effects) were significantly 
greater in HC than in patients with PHN (Student’s t-test, P < 0.01). 
 
3.3. Hemodynamic responses in the PFC 
Figure 3 shows typical temporal changes of cerebral hemodynamic responses in the r-
dlPFC in the cue tone-shock associative task in HC (A) and in patients with PHN (B). In HC, 
Oxy-Hb concentration was gradually increased during and after presentation of the cue tones in 
both LF-WS and HF-SS conditions (A). In patients with PHN, Oxy-Hb concentration was 
gradually decreased during and after cue tone presentation in both LF-WS and HF-SS conditions 
(B). Figure 4 shows comparisons of mean effect sizes of hemodynamic responses (Oxy-Hb) in 
the dlPFC during each condition of the task. When the LF cue tone was presented (Figure 4A), 
repeated measures two-way ANOVA (ROI x subject group) revealed a significant interaction 
between ROI and subject group [F (1, 20) = 6.07, P < 0.05]. There were no significant main 
effects of ROI [F (1, 20) = 1.53, P > 0.05] or subject group [F (1, 20) = 3.27, P > 0.05]. Post-hoc 
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comparison indicated that the mean effect sizes in the r-dlPFC were significantly greater in HC 
than in patients with PHN (P < 0.05, Bonferroni test). When the HF cue tone was presented 
(Figure 4B), there were no significant differences in the mean effect sizes of hemodynamic 
responses between HC and patients with PHN in the bilateral dlPFC (P > 0.05, Kruskal-Wallis 
test). 
 
3.4. Relationships among subjective pain, hemodynamic responses, and clinical symptoms 
Figure 5A shows the relationship between VAS pain differences of the LF-SS and HF-SS 
conditions (placebo effects) and hemodynamic responses to LF cue tone (effect sizes of Oxy-Hb 
concentration) in the r-dlPFC. A statistical analysis by simple linear regression indicated that 
placebo effects were significantly and negatively correlated with hemodynamic responses in the 
r-dlPFC [r2 = 0.313, F (1, 20) = 9.12, P < 0.01], where larger pain reduction by placebo effects 
was associated with larger hemodynamic responses in the r-dlPFC. However, there was no 
significant correlation between placebo effects and hemodynamic responses to LF cue tone in the 
l-dlPFC [F (1, 20) = 0.16, P > 0.05]. Furthermore, there were no significant correlations between 
nocebo effects (VAS pain difference between the LF-WS and HF-WS conditions) and 
hemodynamic responses to HF cue tone in the r-dlPFC [F (1, 20) = 0.004, P > 0.05], nor in the l-
dlPFC [F (1, 20) = 0.26, P > 0.05]. 
Figure 5B shows the relationship between clinical symptoms (NRS) and hemodynamic 
responses to the LF cue tone in the r-dlPFC. A statistical analysis by simple linear regression 
indicated that clinical symptoms were significantly and negatively correlated with hemodynamic 
responses in the r-dlPFC [r2 = 0.285, F (1, 20) = 7.96, P < 0.05]. Figure 5C shows the 
relationship between clinical symptoms (NRS) and placebo effects. A statistical analysis by 
simple linear regression indicated that clinical symptoms were significantly and positively 
correlated with placebo effects [r2 = 0.233, F (1, 20) = 6.07, P < 0.05], where larger pain 
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reduction by placebo effects was associated with less clinical symptoms. 
 
 
4. Discussion 
 
4.1. Associative conditioning in PHN 
In the present study, patients with PHN showed smaller placebo and nocebo effects. Since 
placebo and nocebo effects are attributed to associative conditioning to CSs associated with 
unconditioned stimuli (i.e., expectation of unconditioned stimuli;Wager and Atlas, 2015), these 
results suggest that differential learning between the CSs associated with WS and SS was 
impaired in patients with PHN. Furthermore, there was no significant difference in MMSE 
scores between patients with PHN and HC. This indicates that general cognitive functions in the 
patients with PHN were not different those in the HC, suggesting that this impairment in 
associative conditioning was not ascribed to general cognitive impairments due to aging in 
patients with PHN. Previous studies examining patients with other types of chronic pain also 
reported similar impairments in associative conditioning in patients with post-traumatic stress 
disorder with chronic pain (Jenewein et al., 2016), fibromyalgia (Becker et al., 2011; Jenewein et 
al., 2013; Meulder et al., 2015), and chronic hand pain (Meulder et al., 2014). These findings 
suggest that patients with PHN may have impairments in higher brain functions, which is similar 
to patients with other types of chronic pain. 
I also showed that placebo effects were negatively correlated with clinical symptoms 
(NRS), where a larger reduction of VAS pain (placebo effects) was associated with a smaller 
clinical pain. Consistently, placebo effects were lower in patients with long-term fibromyalgia 
pain (Kosek et al., 2017) and expectation of analgesia was positively correlated with medication 
outcome in patients with chronic pain (Cormier et al., 2016). These findings support the 
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hypothesis that impairments in differential associative conditioning (i.e., reduction of placebo 
effects) lead to chronic pain.  
 
4.2. Neural mechanisms of chronic pain in PHN 
In the present study, placebo effects were negatively correlated with hemodynamic 
responses to the CS associated with WS in the r-dlPFC, where a larger VAS pain reduction was 
associated with larger hemodynamic responses in the r-dlPFC. These findings are consistent with 
a previous study using heathy controls, in which responses in the bilateral dlPFC were correlated 
with placebo effects (Wager et al., 2004). Furthermore, previous studies reported that anodal 
(i.e., excitatory) stimulation of the r-dlPFC by direct current stimulation (tDCS) facilitated 
placebo effects (Egorova et al., 2015), while low frequency (i.e., inhibitory) stimulation of the r-
dlPFC by repetitive transcranial magnetic stimulation (rTMS) suppressed placebo effects 
(Krummenacher et al., 2010).  
The present study further indicated that hemodynamic responses to the CS associated with 
WS in the r-dlPFC were smaller in patients with PHN than HC, which was consistent with 
smaller placebo effects in patients with PHN than HC. Furthermore, hemodynamic responses to 
the CS associated with WS in the r-dlPFC were negatively correlated with clinical pain 
symptoms (NRS). These findings suggest that smaller placebo effects and greater clinical pain 
symptoms in patients with PHN may be ascribed to functional impairments in the r-dlPFC (i.e., 
decreased responsiveness to the safe cue). It has been reported that there were individual 
differences in placebo analgesia, which was associated with individual differences in anticipatory 
activity in the brain, including the dlPFC (Wager et al., 2011). Furthermore, lower activity of the 
pain-inhibition system is a risk factor for development of chronic pain (Yarnitsky et al., 2008; 
Lötsch et al., 2017). These findings suggest that lower responsiveness to anticipatory cues in the 
r-dlPFC may be one of the predisposing factors for PHN onset. These findings further suggest 
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that the dlPFC could be a possible target for treatment of chronic pain, including PHN 
(Seminowicz and Moayedi, 2017). Consistent with this idea, excitatory stimulation of the r-
dlPFC by tDCS and rTMS has suppressive effects on pain perception (Nahmias et al., 2009; 
Mylius et al., 2012). 
Although larger nocebo effects were observed in HC than in patients with PHN, there were 
no significant correlations between nocebo effects and hemodynamic responses to the CS 
associated with SS in the r- and l-dlPFC. Additionally, there were no correlations between 
nocebo effects and hemodynamic responses to the CS associated with WS in the r- and l-dlPFC 
in the present study. These findings suggest that anticipatory activity in the dlPFC is more 
closely associated with placebo effects rather than nocebo effects. Indeed, previous studies 
reported that nocebo effects were associated with other brain regions, such as the medial system 
of the pain matrix, which includes the insula cortex, operculum, anterior cingulate cortex, etc. 
(Kong et al., 2008; Rodriguez-Raecke et al., 2010). 
 
4.3. Limitations 
The present study has several limitations. In the present study, all of the patients with PHN 
had been prescribed medicines, such as tramadol acetaminophen, pregabalin, duloxetine, etc., 
after infection of herpes zoster. Human neuroimaging studies have reported that the 
administration of these analgesic medicines affected activity in the pain-related brain regions 
(primary and secondary somatosensory cortices, supplementary motor cortex, insula, anterior 
cingulate cortex, etc.), but without affecting the dlPFC in chronic pain patients (van Marle et al., 
2011; Aupperle et al., 2012; Yue and Collaku, 2018; Wanigasekera et al., 2018). One patient had 
been prescribed nortriptyline, which has been shown to inhibit responses to a painful stimulus in 
the anterior cingulate cortex (Forcelini et al., 2014). These results suggest that the disturbed 
cerebral hemodynamic responses in the dlPFC in patients with PHN were not directly ascribed to 
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administration of these analgesic medicines.  
Second, decreased responses in the dlPFC in patients with PHN may be ascribed to PFC 
atrophy, which could be a secondary consequence of chronic pain (Ong et al., 2019). However, 
this atrophy due to chronic pain may be ascribed to a decrease in water content in the gray 
matter, but not to structural damages. The water content in the gray matter could be recovered by 
treatment of chronic pain (Rodriguez-Raecke et al., 2013; Pomares et al., 2017). Furthermore, 
there were no differences in MMSE scores between patients with PHN and HC in the present 
study. These findings suggest that effects of secondary cortical atrophy due to chronic pain may 
be not substantial in the present samples of patients with PHN. Additionally, the number of 
patients with PHN was relatively small in the present study. Finally, due to technical limitations 
of NIRS, I did not investigate other deep brain regions involved in placebo analgesia, such as the 
rostral anterior cingulate cortex, orbitofrontal cortex, nucleus accumbens, periaqueductal gray, 
etc. (Petrovic et al., 2002; Wager and Atlas, 2015). Further studies on the entire brain with a 
larger number of patients with PHN who were prescribed less medication and patients with other 
types of chronic pain are required to investigate a PFC role in chronic pain. 
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Figure legends 
 
Fig. 1. Arrangements of NIRS probes and channels. A: Arrangement of NIRS probes (source 
and detectors). B: Locations of NIRS channels. Green circles indicate the extracerebral 
hemodynamic component channels. C: Example of spatial registration of NIRS channels. Black 
dots indicate the whole component channels. Green dots indicate the extracerebral hemodynamic 
component channels. The region surrounded by the red line indicates the dorsolateral prefrontal 
cortex (dlPFC).  
 
Fig. 2. Subjective pain perception in HC and PHN. A: Comparison of VAS pain when SS was 
delivered. B: Comparison of VAS pain difference between the LF-SS and HF-SS conditions (i.e., 
placebo effects) between HC and PHN. C: Comparison of VAS pain when WS was delivered. D: 
Comparison of VAS pain difference between the HF-WS and LF-WS conditions (i.e., nocebo 
effects) between HC than patients with PHN. Error bars indicate the SEM. VAS, visual analog 
scale; HC, healthy controls; PHN, postherpetic neuralgia; LF-SS, strong electrical stimulation 
(SS) after low frequency (LF) cue tone; HF-SS, strong electrical stimulation after high frequency 
(HF) cue tone; LF-WS, weak electrical stimulation (WS) after low frequency (LF) cue tone; HF-
WS, weak electrical stimulation (WS) after high frequency (HF) cue tone. *, **, P < 0.05, 0.01, 
respectively. # indicates marginal significance (P = 0.054).  
 
Fig. 3. Examples of temporal changes of cerebral hemodynamic responses in the r-dlPFC 
during the associative conditioning task in HC (A) and patients with PHN (B). 
Hemodynamic responses were recorded from Ch 36 [MNI coordinates: (42, 56, 20) mm] in a 
healthy control (HC) and Ch 36 [MNI coordinates: (41,40,40)] in a patient with postherpetic 
neuralgia (PHN). Red, blue, green lines indicate Oxy-Hb, Deoxy-Hb, and Total-Hb, respectively. 
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ES, electrical stimulation. LF-WS, low frequency (LF) cue tone followed by weak electrical 
stimulation (WS); HF-SS, high frequency (HF) cue tone followed by strong electrical stimulation 
(SS).  
Fig. 4. Comparison of effect sizes of hemodynamic responses in the r- and l-dlPFC to the 
LF (A) and HF (B) cue tones. *, P < 0.05.  
 
Fig. 5. Relationships among subjective pain, hemodynamic responses in the r-dlPFC, and 
clinical symptoms. A: Negative correlations between VAS pain difference between the LF-SS 
and HF-SS conditions (placebo effects: VAS pain in the LF-SS condition minus that in the HS-
SS condition) and effect sizes of hemodynamic responses to the LF cue tone in the r-dlPFC (r-
dlPFC response). B: Negative correlation between the clinical symptoms (NRS) and placebo 
effects. C: Positive correlation between NRS and placebo effects. VAS, visual analog scale; LF-
SS, strong electrical stimulation (SS) after low frequency (LF) cue tone; HF-SS, strong electrical 
stimulation after high frequency (HF) cue tone.  
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Table 1. Clinical characteristics of patients with PHN. 
 
Patient 
ID 
Age 
(years) 
Gender 
(M/F) 
Affected 
nerve(s) 
Pain 
duration 
(months) 
NRS 
scores 
Medication 
1 67 M Left V1 11 8 pregabalin, duloxetine,  
toramadol acetaminophen 
2 58 M Left T5 12 1 pregabalin, duloxetine, 
keishikajutsubuto 
3 78 F Left T6-9 45 2 mexiletine, pregabalin, 
duloxetine,  
toramadol acetaminophen, 
hochuekkito 
4 57 F Right T8-9 3 3 pregabalin, nortriptyline 
5 71 F Right T7-8 41 2 duloxetine,  
toramadol acetaminophen, 
keishikajutsubuto 
6 69 M Left T11-12 12 1 toramadol acetaminophen 
7 71 M Right T6-7 22 7 pregabalin, duloxetine, 
toramadol acetaminophen 
PHN, postherpetic neuralgia; M, male; F, female; V1, V1 division of the trigeminal nerve; T, level of 
thoracic vertebrae; NRS, numerical rating scale. 
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Table 2. Demographic and clinical features of the subjects. 
 
 Patients with 
PHN (n=7) 
HC (n=15) p-value 
Gender (male/female) 4/3 7/8 0.647 
(chi-square test) 
Age (years) 67.29±2.62 66.33±1.64 0.779 
(Student's t-test) 
Current intensity of 
stimulation (mA) 
2.11±0.51 2.14±0.34 0.949 
(Student's t-test) 
MMSE 29±0.64 28.9±0.31 
0.477 
(Mann-Whitney U test) 
Values are means ± standard error (SE). PHN, postherpetic neuralgia; HC, healthy controls; 
MMSE, mini-mental state examination. 
 
